Is Alnylam a Good Biotech Stock to Buy Now?

After many long years as a clinical-stage biotech, successful new drugs are beginning to pour out of Alnylam (NASDAQ: ALNY). The FDA's currently reviewing the third new drug application from the biotech in as many years.

Unfortunately for bargain shoppers, Alnylam's string of successes hasn't gone unnoticed by a stock market currently enthusiastic for drugmaker stocks. Is Alnylam a buy right now? Or is it a good idea to wait for a pullback?

Image source: Getty Images.

Continue reading

Source Fool.com